510 related articles for article (PubMed ID: 14999601)
1. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
[TBL] [Abstract][Full Text] [Related]
2. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.
Laoprasopwattana K; Libraty DH; Endy TP; Nisalak A; Chunsuttiwat S; Vaughn DW; Reed G; Ennis FA; Rothman AL; Green S
J Infect Dis; 2005 Aug; 192(3):510-9. PubMed ID: 15995967
[TBL] [Abstract][Full Text] [Related]
3. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity.
Vaughn DW; Green S; Kalayanarooj S; Innis BL; Nimmannitya S; Suntayakorn S; Endy TP; Raengsakulrach B; Rothman AL; Ennis FA; Nisalak A
J Infect Dis; 2000 Jan; 181(1):2-9. PubMed ID: 10608744
[TBL] [Abstract][Full Text] [Related]
4. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
[TBL] [Abstract][Full Text] [Related]
5. Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.
Kochel TJ; Watts DM; Gozalo AS; Ewing DF; Porter KR; Russell KL
J Infect Dis; 2005 Mar; 191(6):1000-4. PubMed ID: 15717278
[TBL] [Abstract][Full Text] [Related]
6. Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.
Zivny J; DeFronzo M; Jarry W; Jameson J; Cruz J; Ennis FA; Rothman AL
J Immunol; 1999 Sep; 163(5):2754-60. PubMed ID: 10453018
[TBL] [Abstract][Full Text] [Related]
7. HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses.
Duan ZL; Li Q; Wang ZB; Xia KD; Guo JL; Liu WQ; Wen JS
Virol J; 2012 Nov; 9():259. PubMed ID: 23121866
[TBL] [Abstract][Full Text] [Related]
8. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.
Libraty DH; Young PR; Pickering D; Endy TP; Kalayanarooj S; Green S; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
J Infect Dis; 2002 Oct; 186(8):1165-8. PubMed ID: 12355369
[TBL] [Abstract][Full Text] [Related]
9. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.
Okuno Y; Fukunaga T; Srisupaluck S; Kasemsarn P; Dharakul C; Sangkawibha N
Biken J; 1980 Sep; 23(3):113-21. PubMed ID: 7458894
[TBL] [Abstract][Full Text] [Related]
10. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
Yeh WT; Chen RF; Wang L; Liu JW; Shaio MF; Yang KD
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):84-90. PubMed ID: 16965355
[TBL] [Abstract][Full Text] [Related]
11. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.
Ramanathan MP; Kuo YC; Selling BH; Li Q; Sardesai NY; Kim JJ; Weiner DB
Vaccine; 2009 Oct; 27(46):6444-53. PubMed ID: 19580892
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of interferences between dengue vaccine serotypes in a monkey model.
Guy B; Barban V; Mantel N; Aguirre M; Gulia S; Pontvianne J; Jourdier TM; Ramirez L; Gregoire V; Charnay C; Burdin N; Dumas R; Lang J
Am J Trop Med Hyg; 2009 Feb; 80(2):302-11. PubMed ID: 19190230
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune activation in children with acute dengue virus infections is modulated by apoptosis.
Myint KS; Endy TP; Mongkolsirichaikul D; Manomuth C; Kalayanarooj S; Vaughn DW; Nisalak A; Green S; Rothman AL; Ennis FA; Libraty DH
J Infect Dis; 2006 Sep; 194(5):600-7. PubMed ID: 16897658
[TBL] [Abstract][Full Text] [Related]
15. Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.
Brandler S; Ruffie C; Najburg V; Frenkiel MP; Bedouelle H; Desprès P; Tangy F
Vaccine; 2010 Sep; 28(41):6730-9. PubMed ID: 20688034
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.
Laoprasopwattana K; Libraty DH; Endy TP; Nisalak A; Chunsuttiwat S; Ennis FA; Rothman AL; Green S
J Infect Dis; 2007 Apr; 195(8):1108-16. PubMed ID: 17357046
[TBL] [Abstract][Full Text] [Related]
17. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.
Libraty DH; Endy TP; Houng HS; Green S; Kalayanarooj S; Suntayakorn S; Chansiriwongs W; Vaughn DW; Nisalak A; Ennis FA; Rothman AL
J Infect Dis; 2002 May; 185(9):1213-21. PubMed ID: 12001037
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus infections in the first 2 years of life and the kinetics of transplacentally transferred dengue neutralizing antibodies in thai children.
Pengsaa K; Luxemburger C; Sabchareon A; Limkittikul K; Yoksan S; Chambonneau L; Chaovarind U; Sirivichayakul C; Lapphra K; Chanthavanich P; Lang J
J Infect Dis; 2006 Dec; 194(11):1570-6. PubMed ID: 17083042
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte responses to heterologous secondary dengue virus infections.
Rothman AL
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
[TBL] [Abstract][Full Text] [Related]
20. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
